MS is characterized by an immune attack on myelin, leading to sensory and motor problems. While current drugs effectively reduce relapses, they do not halt the gradual deterioration that begins early in the disease. Addressing mitochondrial function and environmental factors is essential for a more comprehensive approach to managing MS.
